摘要
目的观察单唾液酸四己糖神经节苷脂钠注射液对新生儿缺氧缺血性脑病(HIE)的治疗效果。方法治疗组30例HIE患儿在常规治疗的同时予单唾液酸四己糖神经节苷脂钠注射液,对照组33例采用常规治疗,以新生儿行为神经测定(NBNA)进行疗效评价。结果两组NBNA评分差异具有统计学意义(P<0.05)。结论单唾液酸四己糖神经节苷脂钠注射液可以减轻新生儿缺氧缺血性脑病神经功能损害,改善预后。
Objective To observe the effect of Monosialotetrahexosylganglioside sodium injection on neonatal hypoxic is chemic encephalopathy （HIE）. Methods All of 30 patients with HIE of the treatment group were applied Monosialotetrahexosylganglioside sodium injection based on the conventional treatment, while the control group of 33 patients was treated with conventional therapy. The neonatal behavioral neurological assessment （NBNA） was applied to evaluate the curative effect between the two groups. Results The differences of NBNA scores between treatment group and control group was significant （P 〈 0.05）. Conclusion The Monosialotetrahexosylganglioside sodium injection can reduce neurological impairment on the HIE, and improve prognosis.
出处
《中国现代医生》
2012年第6期61-62,共2页
China Modern Doctor
关键词
新生儿缺氧缺血性脑病
单唾液酸四己糖神经节苷脂钠注射液
新生儿行为神经测定
Neonatal hypoxic ischemic encephalopathy
Monosialotetrahexosylganglioside sodium injection
Neonatal behavioral neurological assessment
